<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP06744545B8W1" file="EP06744545W1B8.xml" lang="en" country="EP" doc-number="1948782" kind="B8" correction-code="W1" date-publ="20120912" status="c" dtd-version="ep-patent-document-v1-4">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFR..GRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..............................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  2999001/0</B007EP></eptags></B000><B100><B110>1948782</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20120912</date></B140><B150><B151>W1</B151><B153>84</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>06744545.2</B210><B220><date>20060421</date></B220><B240><B241><date>20080318</date></B241><B242><date>20090903</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>MU05052005</B310><B320><date>20050425</date></B320><B330><ctry>IN</ctry></B330></B300><B400><B405><date>20120912</date><bnum>201237</bnum></B405><B430><date>20080730</date><bnum>200831</bnum></B430><B450><date>20120801</date><bnum>201231</bnum></B450><B452EP><date>20120203</date></B452EP><B480><date>20120912</date><bnum>201237</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C12N   1/20        20060101AFI20080327BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  39/39        20060101ALI20090512BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>IMPFSTOFFADJUVANTIEN</B542><B541>en</B541><B542>VACCINE ADJUVANTS</B542><B541>fr</B541><B542>ADJUVANTS DE VACCINS</B542></B540><B560><B561><text>WO-A2-03/049667</text></B561><B561><text>WO-A2-03/075825</text></B561><B562><text>GORMUS BOBBY J ET AL: "Under-explored experimental topics related to integral mycobacterial vaccines for leprosy" EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, vol. 2, no. 6, 1 December 2003 (2003-12-01), pages 791-804, XP009115719 ISSN: 1476-0584</text></B562><B562><text>STILLS HAROLD F JR: "Adjuvants and antibody production: Dispelling the myths associated with Freund's complete and other adjuvants" ILAR JOURNAL, vol. 46, no. 3, 1 January 2005 (2005-01-01), pages 280-293, XP001539142 ISSN: 1084-2020</text></B562><B562><text>SUR PRABIR KUMAR ET AL: "Role of mycobacterium w as adjuvant treatment of lung cancer (non-small cell lung cancer)." JOURNAL OF THE INDIAN MEDICAL ASSOCIATION FEB 2003, vol. 101, no. 2, February 2003 (2003-02), page 118 , 120, XP009115704 ISSN: 0019-5847</text></B562><B562><text>SHARMA P ET AL: "Mycobacterium w vaccine, a useful adjuvant to multidrug therapy in multibacillary leprosy: a report on hospital based immunotherapeutic clinical trials with a follow-up of 1-7 years after treatment." LEPROSY REVIEW JUN 2000, vol. 71, no. 2, June 2000 (2000-06), pages 179-192, XP009115711 ISSN: 0305-7518</text></B562><B562><text>PETROVSKY N.: 'Vaccine Adjuvants: Current State and Future Trends' IMMUNOLOGY AND CELL BIOLOGY vol. 82, 2004, pages 488 - 496, XP009078668</text></B562><B565EP><date>20090518</date></B565EP></B560></B500><B700><B720><B721><snm>KHAMAR, Bakulesh, Mafatlal</snm><adr><str>Cadila Pharmaceuticals Ltd.
Cadila Corporate Campus
Sarkhej-Dholka Road</str><city>Bhat
Ahmedabad 382 210
Gujarat</city><ctry>IN</ctry></adr></B721><B721><snm>MODI, Indravadan, Ambalal</snm><adr><str>Cadila Pharmaceuticals Ltd.
Cadila Corporate Campus
Sarkhej-Dholka Road</str><city>Bhat
Ahmedabad 382 210
Gujarat</city><ctry>IN</ctry></adr></B721><B721><snm>MODI, Rajiv, Indravadan</snm><adr><str>Cadila Pharmaceuticals Ltd.
Cadila Corporate Campus
Sarkhej-Dholka Road</str><city>Bhat
Ahmedabad 382 210
Gujarat</city><ctry>IN</ctry></adr></B721><B721><snm>GHOSH, Prasanta, Kumar</snm><adr><str>Cadila Pharmaceuticals Ltd.
Cadila Corporate Campus
Sarkhej-Dholka Road</str><city>Bhat
Ahmedabad 382 210
Gujarat</city><ctry>IN</ctry></adr></B721><B721><snm>DESAI, Nirav</snm><adr><str>Cadila Pharmaceuticals Ltd.
Cadila Corporate Campus
Sarkhej-Dholka Road</str><city>Bhat
Ahmedabad 382 210
Gujarat</city><ctry>IN</ctry></adr></B721></B720><B730><B731><snm>Cadila Pharmaceuticals Limited</snm><iid>100750046</iid><irf>68.9744/01</irf><adr><str>Cadila Corporate Campus 
Sarkhej-Dholka Road</str><city>Bhat, Ahmedabad 382 210</city><ctry>IN</ctry></adr></B731></B730><B740><B741><snm>Rigby, Barbara Nicole</snm><iid>101067067</iid><adr><str>Dehns 
St Bride's House 
10 Salisbury Square</str><city>London EC4Y 8JD</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>IB2006000978</anum></dnum><date>20060421</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2006114680</pnum></dnum><date>20061102</date><bnum>200644</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
